Bishoy M. Faltas, MD, discusses the current use of genomic testing to guide urothelial cancer treatment.
Bishoy Faltas, MD
Advertisement
Articles by Bishoy Faltas, MD
Bishoy Faltas, MD, clinical fellow, Weill Cornell Medical College, discusses clonal heterogeneity in platinum-resistant metastatic urothelial cancer.
Advertisement
Latest Updated Articles
Exploring the Role of Genomic Testing in Urothelial CancerPublished: March 1st 2022 | Updated:
Clonal Heterogeneity in Urothelial CancerPublished: March 5th 2015 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
